These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 16387583

  • 1. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
    [Abstract] [Full Text] [Related]

  • 2. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]

  • 3. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 4. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 5. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 10. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, Irani AM.
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [Abstract] [Full Text] [Related]

  • 11. Predicting short term response to anti-inflammatory therapy in young children with asthma.
    Zielen S, Christmann M, Kloska M, Dogan-Yildiz G, Lieb A, Rosewich M, Schubert R, Rose MA, Schulze J.
    Curr Med Res Opin; 2010 Feb; 26(2):483-92. PubMed ID: 20001651
    [Abstract] [Full Text] [Related]

  • 12. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.
    Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, Hodgdon K, Morgan W, Sorkness CA, Lemanske RF, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2003 Nov; 112(5):883-92. PubMed ID: 14610474
    [Abstract] [Full Text] [Related]

  • 13. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG, Rodrigues MT, Zamel N, Chapman KR.
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [Abstract] [Full Text] [Related]

  • 14. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
    Bukstein DA, Luskin AT, Bernstein A.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136
    [Abstract] [Full Text] [Related]

  • 15. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 May; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

  • 16. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ.
    Am J Respir Crit Care Med; 2003 May 01; 167(9):1232-8. PubMed ID: 12456382
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T.
    Eur J Pediatr; 2008 Jul 01; 167(7):731-6. PubMed ID: 18214538
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M, Bruce C, Sjöstrand M, Arvidsson P, Lötvall J.
    Allergy; 2005 Jan 01; 60(1):65-70. PubMed ID: 15575933
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma.
    Knuffman JE, Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Martinez FD, Bacharier LB, Strunk RC, Szefler SJ, Zeiger RS, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2009 Feb 01; 123(2):411-6. PubMed ID: 19121860
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C.
    J Pediatr; 2005 Aug 01; 147(2):213-20. PubMed ID: 16126052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.